Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Dare Bioscience, Inc.

NASDAQ: DAREHealthcare / Biotechnology / -
0.7500.00Vol 90 2631Y Perf -70.08%
Dec 12th, 2018 15:59
BID0.75 ASK0.76
Open0.76 Previous Close0.75
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.94 
Analyst Rating
Strong Buy 1.00
Potencial %
692.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
0.70 
Earnings Date
13th Nov 2018

Today's Price Range

0.730.78

 

52wk Range

0.733.59

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-17.58%
3 Months
-26.47%
6 Months
-43.61%
1 Year
-70.08%
3 Years
-97.56%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
DARE0.750.00000.00
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.00
Current Ratio
8.50
Long Term Debt to Total Capital
-
Total Debt to Equity
0.00
Interest Coverage
-70.10
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-644.10
EBITDA Margin
-644.10
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.02
PS Ratios
22.95
Price to Cash Flow
-
Price to Free Cash Flow
-1.10
Cash Flow Per Share
-0.91
Price to Tangible Book
1.02
Book Value per Share
0.84
Enterprise Value (in ths.)
286
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
451.21
ROE last 12 Months
-143.41
Return on Assets (5Y Avg)
-181.82
ROA last 12 Months
-134.77
Return on Capital (5Y Avg)
-
ROC last 12 Months
-143.41
Return on invested Capital Q
-23.62
Return on invested Capital Y
-177.72
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.23-0.230.00
Q01 2018--0.28-
Q04 2017--0.49-
Q02 2017--1.42-
Q01 2017-3.10-2.2029.03
Q03 2016-4.30-3.6016.28
Q02 2016-4.80-4.0016.67
Q01 2016-4.20-4.90-16.67
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.27-12.50Negative
12/2018 FY-1.05-34.62Negative
3/2019 QR-0.3169.00Positive
12/2019 FY-1.05--
Next Report Date-
Estimated EPS Next Report-0.23
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume90 263
Shares Outstanding (in ths.)11 420
Trades Count206
Dollar Volume62 958
Avg. Volume566 487
Avg. Weekly Volume2 293 211
Avg. Monthly Volume623 318
Avg. Quarterly Volume273 415

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

42%58%

Bearish Bullish

77%23%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News